arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Aurinia Pharmaceuticals Inc

AUPH Health Care Biotechnology: Pharmaceutical Preparations
$16.08
Today
as of Sep 4, 16:46 ET
Last 30 days +7.49% Jul 28 → Sep 04
$14.35 $15.14 $15.92 $16.70 $17.49 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$15.97
High
$16.22
Low
$15.93
Volume
$526,580
Avg Vol
$1M
Mkt Cap
$2.1B
P/E (TTM)
30.34
Beta
—
52w High
$19.25
52w Low
$10.34
Div Yield
—
Shares Out
$133M

Recent Press Releases & News last 60 days · 10 items

Aug 28 · 21:14 Insider Monkey
Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)?
Aug 20 · 07:11 Simply Wall St.
How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback
Aug 20 · 00:16 Simply Wall St.
Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap After A 74% Gain
▸ Show all 10 press releases & news Free account →

Overview

52-week range
$10
$19
64% of range
Avg surprise (last 3)
+44.3%
Avg reaction (last 2)
-2.7%
50% positive
Latest IV / EM
34%
EM ±5.3% · $16 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.08$0.13$0.18$0.23$0.28 Actual $0.16Est $0.08Actual $0.16Est $0.17Actual $0.25Est $0.18Actual $0.28 Mar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$0$22M$44M$66M$87M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.28 — — — — financials
Thu May 7, 2026Mar/2026 $0.25 $0.18 +38.9% +56.2% -6.8% earnings
Thu Jul 31, 2025Jun/2025 $0.16 $0.17 -5.9% — — earnings
Mon May 12, 2025Mar/2025 $0.16 $0.08 +100.0% — +1.5% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$83M$78M——$70M$62M——
Cost of revenue$7M$7M—$8M$7M$9M—$6M
Gross profit————————
Operating income$46M$41M——$20M$22M——
Net income$37M$34M——$22M$23M——
EPS (diluted)$0.28$0.25——$0.16$0.16——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$180M$41M—$73M$53M$66M—$37M
Inventory$45M$46M$46M$45M$47M$46M$39M$39M
Total current assets$541M$480M$492M$439M$409M$406M$447M$440M
Total assets$792M$724M$752M$528M$503M$505M$551M$549M
Long-term debt————————
Total liabilities$177M$156M$170M$162M$167M$155M$173M$161M
Total equity$615M$568M$581M$366M$335M$350M$377M$388M

Implied volatility — last 90 days

22%62%101%140%180% Jun 07 — IV 50% · EM ±6.9%Jun 08 — IV 54% · EM ±7.2%Jun 09 — IV 47% · EM ±5.9%Jun 10 — IV 57% · EM ±6.7%Jun 11 — IV 46% · EM ±5.0%Jun 12 — IV 43% · EM ±4.4%Jun 15 — IV 39% · EM ±2.8%Jun 16 — IV 84% · EM ±4.9%Jun 17 — IV 111% · EM ±4.6%Jun 19 — IV 43% · EM ±9.6%Jun 22 — IV 52% · EM ±10.8%Jun 23 — IV 39% · EM ±7.9%Jun 24 — IV 46% · EM ±9.1%Jun 25 — IV 49% · EM ±9.5%Jun 26 — IV 51% · EM ±9.7%Jun 29 — IV 55% · EM ±9.8%Jun 30 — IV 39% · EM ±6.8%Jul 01 — IV 46% · EM ±7.8%Jul 02 — IV 47% · EM ±7.5%Jul 03 — IV 48% · EM ±7.5%Jul 06 — IV 66% · EM ±9.2%Jul 07 — IV 71% · EM ±9.4%Jul 08 — IV 47% · EM ±5.9%Jul 09 — IV 47% · EM ±5.6%Jul 10 — IV 43% · EM ±4.8%Jul 13 — IV 84% · EM ±7.0%Jul 14 — IV 48% · EM ±3.4%Jul 15 — IV 63% · EM ±3.7%Jul 16 — IV 180% · EM ±7.5%Jul 20 — IV 50% · EM ±11.8%Jul 21 — IV 48% · EM ±11.3%Jul 22 — IV 60% · EM ±13.7%Jul 23 — IV 47% · EM ±10.7%Jul 24 — IV 46% · EM ±10.3%Jul 27 — IV 70% · EM ±14.6%Jul 28 — IV 49% · EM ±10.0%Jul 29 — IV 46% · EM ±9.2%Jul 30 — IV 42% · EM ±8.2%Jul 31 — IV 63% · EM ±12.1%Aug 03 — IV 53% · EM ±9.4%Aug 04 — IV 70% · EM ±12.1%Aug 05 — IV 71% · EM ±11.8%Aug 06 — IV 52% · EM ±8.4%Aug 07 — IV 56% · EM ±8.7%Aug 10 — IV 103% · EM ±14.2%Aug 11 — IV 99% · EM ±13.0%Aug 12 — IV 67% · EM ±8.4%Aug 13 — IV 35% · EM ±4.1%Aug 14 — IV 64% · EM ±7.1%Aug 17 — IV 67% · EM ±5.6%Aug 18 — IV 23% · EM ±1.6%Aug 19 — IV 50% · EM ±2.9%Aug 20 — IV 118% · EM ±4.9%Aug 24 — IV 38% · EM ±7.8%Aug 25 — IV 25% · EM ±5.1%Aug 26 — IV 38% · EM ±7.7%Aug 27 — IV 98% · EM ±19.1%Aug 28 — IV 42% · EM ±8.0%Aug 31 — IV 32% · EM ±5.6%Sep 01 — IV 27% · EM ±4.7%Sep 02 — IV 46% · EM ±7.7%Sep 03 — IV 46% · EM ±7.4%Sep 04 — IV 34% · EM ±5.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in